Alterome Therapeutics, Inc.
San Diego, US · Founded 2021 · Delaware corporation · 42 employees on LinkedIn · 6 known investors
Find your way into Alterome Therapeutics, Inc.
7 people in our graph share verified history with the Alterome Therapeutics, Inc. team — schools, employers, funds. One of them is your warm intro.
Lucy Liuunlockedknows Eric A. Murphy · together at Sidewinder Therapeutics (overlapped)
×2knows the team · via Alterome Therapeutics, Inc.
×2knows the team · via Kinnate Biopharma Inc.
×2knows the team · via Crownbio
Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic. It focuses on hard-to-drug cancer targets such as mutant KRAS and mutant AKT E17K across malignancies including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancers.
Founders & leadership
Alterome Therapeutics, Inc. was founded in 2021 by Eric A. Murphy.
EA
Eric A. MurphyinCEO, CSO, and Co-Founder2021–2024Eric A. Murphy leads Alterome Therapeutics, a clinical-stage precision oncology company developing small-molecule therapies targeting mutant KRAS and mutant AKT across multiple cancer types. He has held roles in academic, biotech, pharmaceutical, and contract research organizations, with expertise in cancer research, drug discovery, pharmacology, and drug development.
RB
Ryan B. CorcoranNamed on SEC filing
Board
CG
AG
Investors · 6
Reported raises · per SEC filings
Form D private placements$63.8M disclosed across 1 round · 2021
▶$63.8MraisedJan 2022 · 9 investors · BiotechnologyRule 506(b)
▶$63.8MraisedJan 2022 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric A. MurphyExecutive Officer, Director, Promoter
- Thilo SchroederDirector
- Ryan B. CorcoranDirector, Promoter
- Carl GordonDirector
- Arjun GoyalDirector
- Offering amount
- $63.8M
- Amount sold
- $63.8M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Alterome Therapeutics, Inc. went on to found or lead other companies.
Competitors · 8
by search overlap
Immunome50 shared keywordsImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.
Noveome Biotherapeutics40 shared keywordsNoveome is a clinical-stage biopharmaceutical company developing ST266, a multi-targeted secretome containing hundreds of biologically active proteins designed for neuroprotection, inflammation modulation, and tissue healing. The company is investigating ST266's potential across ophthalmology, neurology, dermatology, and other therapeutic areas.
Nucleome32 shared keywordsNucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.
Cellanome31 shared keywordsCellanome develops a live-cell analysis platform using CellCage technology to create controlled microenvironments that enable researchers to observe cell behavior and molecular changes over time. The platform generates structured multimodal data for life sciences researchers and biopharma companies focused on oncology, neuroscience, immunology, and aging research.
nChroma Bio26 shared keywordsnChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.
Myome26 shared keywordsMyOme provides genomic insights and clinical genetic screening reports to help individuals and healthcare providers assess risks for hereditary conditions and make informed health decisions.
Bioworld21 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Freenome21 shared keywordsFreenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
Companies competing with Alterome Therapeutics, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Alterome Therapeutics, Inc. do?
- Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic. It focuses on hard-to-drug cancer targets such as mutant KRAS and mutant AKT E17K across malignancies including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancers.
- Who founded Alterome Therapeutics, Inc.?
- Alterome Therapeutics, Inc. was founded by Eric A. Murphy in 2021.
- Who are Alterome Therapeutics, Inc.'s investors?
- Alterome Therapeutics, Inc.'s investors include Canaan Partners, Nextech Invest, OrbiMed, Vida Ventures, Digitalis Ventures, NVIDIA.
- How much funding has Alterome Therapeutics, Inc. raised?
- Alterome Therapeutics, Inc. has disclosed $63.8M raised across 1 round.
- Where is Alterome Therapeutics, Inc. headquartered?
- Alterome Therapeutics, Inc. is headquartered in San Diego, US.